Press Releases

SECAUCUS, N.J., Nov. 20, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on January 29, 2020 to shareholders of record of Quest Diagnostics common stock on J

- CannaPharmacy Transaction Limited to Pennsylvania Cultivation Operations- $62.5M CAD Additional Diversified Funding, Strengthening Financial Position- Termination of Torian Capital Partners Financing PHOENIX, Nov. 20, 2019 /PRNewswire/ -- 

CAMBRIDGE, Mass., Nov. 20, 2019 /PRNewswire/ -- Werewolf Therapeutics, an oncology biotherapeutics company advancing a pipeline of next generation, transformative cancer treatments, today announced the completion of its $56 million Series A financing. The company is developing novel immuno-stimulatory therapeutics designed to act select

INDIANAPOLIS, Nov. 20, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to invest $400 million in its manufacturing facilities at its Lilly Technology Center campus in Indianapolis. The plans are driven by increasing demand for Lilly's current medicines, and they provide addit

IRVING, Texas, Nov. 20, 2019 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that

BRIDGEWATER, N.J. and NEW YORK, Nov. 20, 2019 /PRNewswire/ -- Sanofi announced today an enterprise-wide collaboration with health care technology company Aetion that will integrate Sanofi's real-world data platform, DARWIN, with the Aetion Evidence Platform® with the objective of advancing more efficient use of

TORONTO, Nov. 20, 2019 /PRNewswire/ - Baylis Medical announced today the first Arctic Front™ Advance Cryoballoon procedures performed using the VersaCross Transseptal Solution. The VersaCross solution is the world's first all-in-one left-heart access device featuring an atraumatic RF-tipped wire, which acts as both puncture device and exchange rail. The puncture wi

SOUTH SAN FRANCISCO, Calif., Nov. 20, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced it has presented data from an ongoing Phase 1/2 clinical trial entitled "A Phase 1/2 Study in Patients with Solid Tumors Harbo

SANTA MONICA, Calif., Nov. 20, 2019 /PRNewswire/ -- PatientPop, the leader in healthcare practice growth technology, today announced

GENEVA, Nov. 21, 2019 /PRNewswire/ -- AnaPath Services GmbH, the Swiss CRO specialized in histopathology, has acquired legacy Envigo CRS S.A.U. a CRO for non-clinical safety assessment on November 5th, 2019. With this step Envigo CRS was renamed to AnaPath Research S.A.U. Furthermore Jorge